Correlation and Causation in the Perspective of COVID-19: An Empirical Study on Canonical Correlation Analysis

COVID-19 has an immense effect on the Globe, crossing 53,86,95,729 affected in more than 220 nations, with 63,18,093 individuals deceased. Various countries released COVID-19 protocols to enclose its spread to control the pandemic. This research article illustrates the Effect of COVID-19 on aged people (age>50), diabetes individuals, and individuals with smoking habits concerning the cause of death. An attempt has been made to identify the predominant variables for the cause of death due to COVID-19. IBM SPSS statistical tool enabled by Canonical Correlation Analysis (CCA) is used for simulation. Data were gathered from the Kaggle, an open repository for 2020. Based on the results obtained, predictions regarding the Cause and Effect of COVID-19 are discussed.

[1]  Dasari Naga Vinod,et al.  Fully automated unified prognosis of Covid-19 chest X-ray/CT scan images using Deep Covix-Net model , 2021, Computers in Biology and Medicine.

[2]  Lin Qiu,et al.  The association of diabetes and the prognosis of COVID-19 patients: A retrospective study , 2020, Diabetes Research and Clinical Practice.

[3]  Q. Xiao,et al.  COVID-19 and China’s Hotel Industry: Impacts, a Disaster Management Framework, and Post-Pandemic Agenda , 2020, International Journal of Hospitality Management.

[4]  Dasari Naga Vinod,et al.  Data science and the role of Artificial Intelligence in achieving the fast diagnosis of Covid-19 , 2020, Chaos, Solitons & Fractals.

[5]  P. Hegyi,et al.  Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysis , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[6]  S. Pathak,et al.  Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[7]  Wei Liu,et al.  Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis , 2020, Heart.

[8]  D. Klonoff,et al.  Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States , 2020, Journal of diabetes science and technology.

[9]  N. Vyas,et al.  Assessment of preparedness against emerging infectious disease among private hospitals in a district of South India , 2020, Medical Journal Armed Forces India.

[10]  D. Sin,et al.  ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 , 2020, European Respiratory Journal.

[11]  Xin Zhou,et al.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.

[12]  Zhaofeng Chen,et al.  Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis , 2020, International Journal of Infectious Diseases.

[13]  E. McBryde.  The value of early transmission dynamic studies in emerging infectious diseases , 2020, The Lancet Infectious Diseases.

[14]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[15]  R. Alford,et al.  The Novel and Endemic Pathogen Hypotheses: Competing Explanations for the Origin of Emerging Infectious Diseases of Wildlife , 2005 .

[16]  D. Morens,et al.  Summary of antibody workshop: The Role of Humoral Immunity in the Treatment and Prevention of Emerging and Extant Infectious Diseases. , 1997, The Journal of infectious diseases.